Search research articles
Contact Us
Filters
Showing results (291-300 of 329) with videos related to
Page
of 33
Sort By:
ACS Chemical Neuroscience
|
October 23, 2018
Comment on " In Vivo [<sup>18</sup>F]GE-179 Brain Signal Does Not Show NMDA-Specific Modulation with Drug Challenges in Rodents and Nonhuman Primates"
Colm J McGinnity, Erik Årstad, Katherine Beck, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 15, 2026
New approaches to clinical research for people with schizophrenia
Katherine Beck, Matthew Broome, Saeed Farooq, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
April 19, 2022
Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort study
Emma Butler, Toby Pillinger, Kirsten Brown, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 13, 2019
Serotonin release measured in the human brain: a PET study with [<sup>11</sup>C]CIMBI-36 and d-amphetamine challenge
David Erritzoe, Abhishekh H Ashok, Graham E Searle, et al.
Schizophrenia Bulletin
|
April 1, 2020
Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome
Gemma Modinos, Paul Allen, Andre Zugman, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
July 23, 2025
The effects of dopamine receptor antagonist and partial agonist antipsychotics on the glutamatergic system: double-blind, randomised, placebo-controlled <sup>1</sup>H-MRS cross-over study in healthy volunteers
Uzma Zahid, Martin Osugo, Pierluigi Selvaggi, et al.
Human Brain Mapping
|
October 13, 2020
Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosis
George Gifford, Nicolas Crossley, Sarah Morgan, et al.
The Lancet. Child & Adolescent Health
|
June 19, 2024
Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysis
Maria Rogdaki, Robert A McCutcheon, Enrico D'Ambrosio, et al.
BMJ Open
|
November 21, 2022
Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort study
Edward Millgate, Kira Griffiths, Alice Egerton, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 19, 2022
The association between <i>N</i>-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controls
Katherine Beck, Atheeshaan Arumuham, Stefan Brugger, et al.
Page
of 33
Search research articles
Search
Showing results (291-300 of 329) with videos related to
Sort By:
Page
of 33
ACS Chemical Neuroscience
|
October 23, 2018
Comment on " In Vivo [<sup>18</sup>F]GE-179 Brain Signal Does Not Show NMDA-Specific Modulation with Drug Challenges in Rodents and Nonhuman Primates"
Colm J McGinnity, Erik Årstad, Katherine Beck, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
May 15, 2026
New approaches to clinical research for people with schizophrenia
Katherine Beck, Matthew Broome, Saeed Farooq, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
April 19, 2022
Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort study
Emma Butler, Toby Pillinger, Kirsten Brown, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 13, 2019
Serotonin release measured in the human brain: a PET study with [<sup>11</sup>C]CIMBI-36 and d-amphetamine challenge
David Erritzoe, Abhishekh H Ashok, Graham E Searle, et al.
Schizophrenia Bulletin
|
April 1, 2020
Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome
Gemma Modinos, Paul Allen, Andre Zugman, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
July 23, 2025
The effects of dopamine receptor antagonist and partial agonist antipsychotics on the glutamatergic system: double-blind, randomised, placebo-controlled <sup>1</sup>H-MRS cross-over study in healthy volunteers
Uzma Zahid, Martin Osugo, Pierluigi Selvaggi, et al.
Human Brain Mapping
|
October 13, 2020
Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosis
George Gifford, Nicolas Crossley, Sarah Morgan, et al.
The Lancet. Child & Adolescent Health
|
June 19, 2024
Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysis
Maria Rogdaki, Robert A McCutcheon, Enrico D'Ambrosio, et al.
BMJ Open
|
November 21, 2022
Cognitive function and treatment response trajectories in first-episode schizophrenia: evidence from a prospective cohort study
Edward Millgate, Kira Griffiths, Alice Egerton, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 19, 2022
The association between <i>N</i>-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controls
Katherine Beck, Atheeshaan Arumuham, Stefan Brugger, et al.
Page
of 33